Resumo

DOLCINI, G et al. Prevalence of human immunodeficiency virus (HIV)- Trypanosoma cruzi co-infection and injectable-drugs abuse in a Buenos Aires health center. Rev. argent. microbiol. [online]. 2008, vol.40, n.3, pp.164-166. ISSN 0325-7541.

The aim of this study was to evaluate the prevalence of human immunodeficiency virus (HIV)- Trypanosoma cruzi co-infection in a Buenos Aires health center. A retrospective analysis of the clinical charts of 602 HIV-infected patients was performed. Only 51.3% of the patients were evaluated against T. cruzi. The global co-infection prevalence was 4.2%, being more frequent among injectable drug users (IDU) (8.9% vs. 2.6%, p<0.05). The indication of T. cruzi testing should be stressed for HIV-infected patients, especially in those centers where IDU are assisted.

Palavras-chave : HIV; Trypanosoma cruzi; IDU.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )